Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine

Congestive heart failure (CHF) is the main cause of acute dyspnea in patients presented to an emergency department (ED), and it is associated with high morbidity and mortality. B-type natriuretic peptide (BNP) is a polypeptide, released by ventricular myocytes directly proportional to wall tension,...

Full description

Bibliographic Details
Main Authors: P. Ray, B. Doumenc, C. Chenevier-Gobeaux, S. Delerme
Format: Article
Language:English
Published: SAGE Publishing 2008-01-01
Series:Biomarker Insights
Subjects:
BNP
Online Access:http://la-press.com/article.php?article_id=661
id doaj-332d5da21ac442f596404f3c1327427d
record_format Article
spelling doaj-332d5da21ac442f596404f3c1327427d2020-11-25T03:31:53ZengSAGE PublishingBiomarker Insights1177-27192008-01-013203217Useulness of B Natriuretic Peptides and Procalcitonin in Emergency MedicineP. RayB. DoumencC. Chenevier-GobeauxS. DelermeCongestive heart failure (CHF) is the main cause of acute dyspnea in patients presented to an emergency department (ED), and it is associated with high morbidity and mortality. B-type natriuretic peptide (BNP) is a polypeptide, released by ventricular myocytes directly proportional to wall tension, for lowering renin-angiotensin-aldosterone activation. For diagnosing CHF, both BNP and the biologically inactive NT-proBNP have similar accuracy. Threshold values are higher in elderly population, and in patients with renal dysfunction. They might have also a prognostic value. Studies demonstrated that the use of BNP or NT-proBNP in dyspneic patients early in the ED reduced the time to discharge, total treatment cost. BNP and NT-proBNP should be available in every ED 24 hours a day, because literature strongly suggests the beneficial impact of an early appropriate diagnosis and treatment in dyspneic patients. Etiologic diagnosis of febrile patients who present to an ED is complex and sometimes difficult. However, new evidence showed that there are interventions (including early appropriate antibiotics), which could reduce mortality rate in patients with sepsis. For diagnosing sepsis, procalcitonin (PCT) is more accurate than C-reactive protein. Thus, because of its excellent specificity and positive predictive value, an elevated PCT concentration (higher than 0.5 ng/mL) indicates ongoing and potentially severe systemic infection, which needs early antibiotics (e.g. meningitis). In lower respiratory tract infections, CAP or COPD exacerbation, PCT guidance reduced total antibiotic exposure and/or antibiotic treatment duration.http://la-press.com/article.php?article_id=661dyspneaNT-proBNPBNPheart failureemergency departmentseptic shockcommunity-acquired pneumonia
collection DOAJ
language English
format Article
sources DOAJ
author P. Ray
B. Doumenc
C. Chenevier-Gobeaux
S. Delerme
spellingShingle P. Ray
B. Doumenc
C. Chenevier-Gobeaux
S. Delerme
Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine
Biomarker Insights
dyspnea
NT-proBNP
BNP
heart failure
emergency department
septic shock
community-acquired pneumonia
author_facet P. Ray
B. Doumenc
C. Chenevier-Gobeaux
S. Delerme
author_sort P. Ray
title Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine
title_short Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine
title_full Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine
title_fullStr Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine
title_full_unstemmed Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine
title_sort useulness of b natriuretic peptides and procalcitonin in emergency medicine
publisher SAGE Publishing
series Biomarker Insights
issn 1177-2719
publishDate 2008-01-01
description Congestive heart failure (CHF) is the main cause of acute dyspnea in patients presented to an emergency department (ED), and it is associated with high morbidity and mortality. B-type natriuretic peptide (BNP) is a polypeptide, released by ventricular myocytes directly proportional to wall tension, for lowering renin-angiotensin-aldosterone activation. For diagnosing CHF, both BNP and the biologically inactive NT-proBNP have similar accuracy. Threshold values are higher in elderly population, and in patients with renal dysfunction. They might have also a prognostic value. Studies demonstrated that the use of BNP or NT-proBNP in dyspneic patients early in the ED reduced the time to discharge, total treatment cost. BNP and NT-proBNP should be available in every ED 24 hours a day, because literature strongly suggests the beneficial impact of an early appropriate diagnosis and treatment in dyspneic patients. Etiologic diagnosis of febrile patients who present to an ED is complex and sometimes difficult. However, new evidence showed that there are interventions (including early appropriate antibiotics), which could reduce mortality rate in patients with sepsis. For diagnosing sepsis, procalcitonin (PCT) is more accurate than C-reactive protein. Thus, because of its excellent specificity and positive predictive value, an elevated PCT concentration (higher than 0.5 ng/mL) indicates ongoing and potentially severe systemic infection, which needs early antibiotics (e.g. meningitis). In lower respiratory tract infections, CAP or COPD exacerbation, PCT guidance reduced total antibiotic exposure and/or antibiotic treatment duration.
topic dyspnea
NT-proBNP
BNP
heart failure
emergency department
septic shock
community-acquired pneumonia
url http://la-press.com/article.php?article_id=661
work_keys_str_mv AT pray useulnessofbnatriureticpeptidesandprocalcitonininemergencymedicine
AT bdoumenc useulnessofbnatriureticpeptidesandprocalcitonininemergencymedicine
AT ccheneviergobeaux useulnessofbnatriureticpeptidesandprocalcitonininemergencymedicine
AT sdelerme useulnessofbnatriureticpeptidesandprocalcitonininemergencymedicine
_version_ 1724571088011132928